{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:03:22Z","timestamp":1790352202029,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00393-022-01250-0","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T09:04:55Z","timestamp":1662368695000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lupusnephritis","Lupus nephritis"],"prefix":"10.1007","volume":"82","author":[{"given":"Johanna","family":"Mucke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"2","key":"1250_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly\u00a0JG, O\u2019Keeffe\u00a0AG, Su\u00a0L et\u00a0al (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology 55(2):252\u2013262","journal-title":"Rheumatology"},{"issue":"3","key":"1250_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.kint.2016.03.042","volume":"90","author":"PJ Hoover","year":"2016","unstructured":"Hoover\u00a0PJ, Costenbader\u00a0KH (2016) Insights into the epidemiology and management of lupus nephritis from the U.S. rheumatologist\u2019s perspective. Kidney Int 90(3):487\u2013492","journal-title":"Kidney Int"},{"issue":"8","key":"1250_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","volume":"119","author":"A Doria","year":"2006","unstructured":"Doria\u00a0A, Iaccarino\u00a0L, Ghirardello\u00a0A et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119(8):700\u2013706","journal-title":"Am J Med"},{"issue":"6","key":"1250_CR4","first-page":"1047","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra\u00a0V, Monte\u00a0STC, R\u00faa-Figueroa\u00a0I et al (2017) Juvenile- and adult-onset systemic lupus erythematosus: a\u00a0comparative study in a\u00a0large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol 35(6):1047\u20131055","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1250_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00393-018-0496-4","volume":"77","author":"S Melderis","year":"2018","unstructured":"Melderis\u00a0S et\u00a0al (2018) Lupusnephritis. Z Rheumatol 77(7):593\u2013608. https:\/\/doi.org\/10.1007\/s00393-018-0496-4","journal-title":"Z Rheumatol"},{"issue":"2","key":"1250_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2019","unstructured":"Sethi\u00a0S, Fervenza\u00a0FC (2019) Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant 34(2):193\u2013199","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1250_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema\u00a0IM, Wilhelmus\u00a0S, Alpers\u00a0CE et\u00a0al (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93(4):789\u2013796","journal-title":"Kidney Int"},{"issue":"2","key":"1250_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening\u00a0JJ, D\u2019Agati\u00a0VD, Schwartz\u00a0MM et\u00a0al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J\u00a0Am Soc Nephrol 15(2):241\u2013250","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1250_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis\u00a0A, Kostopoulou\u00a0M, Cheema\u00a0K et al (2020) 2019 update of the joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79(6):713\u2013723","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1250_CR10","doi-asserted-by":"publisher","first-page":"e001263","DOI":"10.1136\/rmdopen-2020-001263","volume":"6","author":"M Kostopoulou","year":"2020","unstructured":"Kostopoulou\u00a0M, Fanouriakis\u00a0A, Cheema\u00a0K et al (2020) Management of lupus nephritis: a\u00a0systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations. RMD Open 6(2):e001263","journal-title":"RMD Open"},{"issue":"Suppl 1","key":"1250_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-020-00785-4","volume":"80","author":"C Fiehn","year":"2021","unstructured":"Fiehn\u00a0C, Ness\u00a0T, Weseloh\u00a0C et al (2021) Sicherheitsmanagement der Therapie mit Antimalariamitteln in der Rheumatologie. Interdisziplin\u00e4re Empfehlungen auf der Basis einer systematischen Literatur-Recherche. Z\u00a0Rheumatol 80(Suppl 1):1\u20139","journal-title":"Z Rheumatol"},{"issue":"3","key":"1250_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00296-013-2898-6","volume":"34","author":"S Mao","year":"2014","unstructured":"Mao\u00a0S, Huang\u00a0S (2014) Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a\u00a0meta-analysis. Rheumatol Int 34(3):381\u2013388","journal-title":"Rheumatol Int"},{"issue":"1","key":"1250_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/rheumatology\/kep346","volume":"49","author":"D Isenberg","year":"2010","unstructured":"Isenberg\u00a0D, Appel\u00a0GB, Contreras\u00a0G et\u00a0al (2010) Influence of race\/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49(1):128\u2013140","journal-title":"Rheumatology"},{"issue":"6","key":"1250_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/art.40079","volume":"69","author":"F Tamirou","year":"2017","unstructured":"Tamirou\u00a0F, Husson\u00a0SN, Gruson\u00a0D et al (2017) Brief report: the Euro-lupus low-dose intravenous cyclophosphamide regimen does not impact the ovarian reserve, as measured by serum levels of anti-M\u00fcllerian hormone. Arthritis Rheumatol 69(6):1267\u20131271","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1250_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel\u00a0GB, Contreras\u00a0G, Dooley\u00a0MA et\u00a0al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J\u00a0Am Soc Nephrol 20(5):1103\u20131112","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1250_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.autrev.2013.10.013","volume":"13","author":"G Ruiz-Irastorza","year":"2014","unstructured":"Ruiz-Irastorza\u00a0G, Danza\u00a0A, Perales\u00a0I et al (2014) Prednisone in lupus nephritis: how much is enough? Autoimmun Rev 13(2):206\u2013214","journal-title":"Autoimmun Rev"},{"issue":"10289","key":"1250_CR17","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","volume":"397","author":"BH Rovin","year":"2021","unstructured":"Rovin\u00a0BH, Teng\u00a0YKO, Ginzler\u00a0EM et al (2021) Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a\u00a0double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 397(10289):2070\u20132080","journal-title":"Lancet"},{"issue":"6","key":"1250_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis\u00a0A, Kostopoulou\u00a0M, Alunno\u00a0A et\u00a0al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78(6):736\u2013745","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1250_CR19","doi-asserted-by":"publisher","first-page":"e000538","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF van Vollenhoven","year":"2021","unstructured":"van Vollenhoven\u00a0RF, Bertsias\u00a0G, Doria\u00a0A et al (2021) 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8(1):e000538","journal-title":"Lupus Sci Med"},{"issue":"12","key":"1250_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","volume":"383","author":"R Furie","year":"2020","unstructured":"Furie\u00a0R, Rovin\u00a0BH, Houssiau\u00a0F et al (2020) Two-year, randomized, controlled trial of belimumab in lupus nephritis. N\u00a0Engl J Med 383(12):1117\u20131128","journal-title":"N Engl J Med"},{"issue":"3","key":"1250_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7326\/M19-0120","volume":"171","author":"B Mehta","year":"2019","unstructured":"Mehta\u00a0B, Luo\u00a0Y, Xu\u00a0J et al (2019) Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis. Ann Intern Med 171(3):164\u2013171","journal-title":"Ann Intern Med"},{"issue":"4","key":"1250_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00393-020-00772-9","volume":"79","author":"R Fischer-Betz","year":"2020","unstructured":"Fischer-Betz\u00a0R, Haase\u00a0I (2020) Schwangerschaft bei Lupus erythematodes \u2013 ein Update. Z\u00a0Rheumatol 79(4):359\u2013366","journal-title":"Z Rheumatol"},{"issue":"10","key":"1250_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17512433.2018.1525293","volume":"11","author":"M Gerosa","year":"2018","unstructured":"Gerosa\u00a0M, Argolini\u00a0LM, Artusi\u00a0C et\u00a0al (2018) The use of biologics and small molecules in pregnant patients with rheumatic diseases. Expert Rev Clin Pharmacol 11(10):987\u2013998","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"1250_CR24","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.semarthrit.2016.03.005","volume":"45","author":"G Emmi","year":"2016","unstructured":"Emmi\u00a0G, Silvestri\u00a0E, Squatrito\u00a0D et\u00a0al (2016) Favorable pregnancy outcome in a\u00a0patient with systemic lupus erythematosus treated with belimumab: A confirmation report. Semin Arthritis Rheum 45(6):e26\u2013e27","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"1250_CR25","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3899\/jrheum.170327","volume":"44","author":"A Kumthekar","year":"2017","unstructured":"Kumthekar\u00a0A, Danve\u00a0A, Deodhar\u00a0A (2017) Use of belimumab throughout 2 consecutive pregnancies in a\u00a0patient with systemic lupus erythematosus. J\u00a0Rheumatol 44(9):1416\u20131417","journal-title":"J Rheumatol"},{"issue":"7","key":"1250_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1177\/0961203319847275","volume":"28","author":"SE Reppe Moe","year":"2019","unstructured":"Reppe Moe\u00a0SE, Molberg \u00d8, Str\u00f8m\u00a0EH et al (2019) Assessing the relative impact of lupus nephritis on mortality in a\u00a0population-based systemic lupus erythematosus cohort. Lupus 28(7):818\u2013825","journal-title":"Lupus"},{"issue":"1","key":"1250_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3904\/kjim.2011.26.1.60","volume":"26","author":"S-H Kang","year":"2011","unstructured":"Kang\u00a0S\u2011H, Chung\u00a0B\u2011H, Choi\u00a0S\u2011R et al (2011) Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 26(1):60\u201367","journal-title":"Korean J Intern Med"}],"updated-by":[{"DOI":"10.1007\/s00393-022-01292-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000}}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01250-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01250-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01250-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:18:53Z","timestamp":1675311533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01250-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01250-0","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00393-022-01292-4","asserted-by":"object"}]},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00393-022-01292-4","URL":"https:\/\/doi.org\/10.1007\/s00393-022-01292-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.\u00a0Mucke<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Sanofi Aventis. \u2013\u00a0Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie Deutschland GmbH & Co. KG, AstraZeneca, Bristol Myers Squibb, Celgene GmbH, Chugai Pharma Germany GmbH, Gilead Sciences Inc., GSK, Janssen-Cilag GmbH, Lilly Deutschlang GmbH, Novartis Pharma GmbH.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: AbbVie Deutschland GmbH & Co. KG, Amgen, AstraZeneca, BMS, Celgene GmbH, Gilead Sciences Inc., GlaxoSmithKline, Novartis Pharma GmbH, Lilly Deutschland GmbH, Medac GmbH, Mylan. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Rheumatologin, Universit\u00e4tsklinikum D\u00fcsseldorf | Vorstandsmitglied Rheumazentrum Rhein-Ruhr | Mitgliedschaft: DGRh e.\u202fV. <b>M.\u00a0Schneider<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Unterst\u00fctzung f\u00fcr LuLa durch GSK und UCB.\u00a0\u2013 Referent f\u00fcr GSK und AstraZeneca. \u2013\u00a0Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: GSK, AstraZeneca und Otsuka Pharma.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor am UKD; Sprecher der Kommission Leitlinien der DGRh.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}